NDC11 31722043031
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 31722-0430-31 | 31722-0430 |
| 31722-430-31 | 31722-430 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eslicarbazepine acetate | ESLICARBAZEPINE ACETATE | Camber Pharmaceuticals, Inc. | 6200ae2e-ac4e-41b6-a1c3-0ea00703d7e3 | 2025-05-23 | Warnings, Adverse reactions | 31722-430-31 31722-430 31722043031 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.